Launch One Acquisition Corp. Cl A (LPAA)

$9.97 -0.01 (-0.09%)
Market Cap 0.00
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 5,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 0.00
Stochastic %K 27%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Launch One Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Oakland, California.

Industry: Shell Companies
Sector: Financial Services
Phone: 510 692 9600
Address:
180 Grand Avenue, Suite 1530, Oakland, United States
SuperGreenToday
SuperGreenToday Apr. 21 at 7:14 PM
$LPAA
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 14 at 1:31 AM
$LPAA RSI: 57.89, MACD: 0.0125 Vol: 0.04, MA20: 10.68, MA50: 10.65 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 22 at 4:52 PM
$LPAA RSI: 59.09, MACD: 0.0092 Vol: 0.01, MA20: 10.64, MA50: 10.62 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PatriciaDeaton1048
PatriciaDeaton1048 Feb. 11 at 2:08 PM
$LPAA LPAA or unknown micro-cap; ticker not widely recognized; likely represents an OTC shell with negligible operations.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 20 at 10:42 AM
$LPAA RSI: 77.17, MACD: 0.0183 Vol: 0.02, MA20: 10.61, MA50: 10.57 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 1 at 3:01 AM
$LPAA Current Stock Price: $10.59
0 · Reply
PersonaPro
PersonaPro Dec. 26 at 10:01 AM
$LPAA This name increasingly trades on execution rhythm rather than speculation about possibilities. Governance alignment matters more at this stage. Missed steps could quickly reignite skepticism. Future returns will be dictated by execution quality, not headlines.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 16 at 3:23 AM
$LPAA
0 · Reply
gapureau
gapureau Oct. 30 at 1:20 PM
$CERO This was the Plan, Stan. But don't worry if there is any real value in CERO's tech, the CEO will find a way to keep it. $LPAA and $CERO have the same CEO. And, a lot of cash! https://www.globenewswire.com/news-release/2024/07/15/2913391/0/en/Launch-One-Acquisition-Corp-Completes-230-0-Million-Initial-Public-Offering.html
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 30 at 12:45 PM
$LPAA Minovia Therapeutics' MNV-201 Receives FDA Fast Track And Rare Pediatric Disease Designations For Pearson Syndrome Treatment
0 · Reply
Latest News on LPAA
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Jan 13, 2026, 10:15 AM EST - 4 months ago

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Launch One, Minovia Therapeutics enter business combination agreement

2025-06-25T12:35:22.000Z - 11 months ago

Launch One, Minovia Therapeutics enter business combination agreement

SuperGreenToday
SuperGreenToday Apr. 21 at 7:14 PM
$LPAA
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 14 at 1:31 AM
$LPAA RSI: 57.89, MACD: 0.0125 Vol: 0.04, MA20: 10.68, MA50: 10.65 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 22 at 4:52 PM
$LPAA RSI: 59.09, MACD: 0.0092 Vol: 0.01, MA20: 10.64, MA50: 10.62 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PatriciaDeaton1048
PatriciaDeaton1048 Feb. 11 at 2:08 PM
$LPAA LPAA or unknown micro-cap; ticker not widely recognized; likely represents an OTC shell with negligible operations.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 20 at 10:42 AM
$LPAA RSI: 77.17, MACD: 0.0183 Vol: 0.02, MA20: 10.61, MA50: 10.57 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 1 at 3:01 AM
$LPAA Current Stock Price: $10.59
0 · Reply
PersonaPro
PersonaPro Dec. 26 at 10:01 AM
$LPAA This name increasingly trades on execution rhythm rather than speculation about possibilities. Governance alignment matters more at this stage. Missed steps could quickly reignite skepticism. Future returns will be dictated by execution quality, not headlines.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 16 at 3:23 AM
$LPAA
0 · Reply
gapureau
gapureau Oct. 30 at 1:20 PM
$CERO This was the Plan, Stan. But don't worry if there is any real value in CERO's tech, the CEO will find a way to keep it. $LPAA and $CERO have the same CEO. And, a lot of cash! https://www.globenewswire.com/news-release/2024/07/15/2913391/0/en/Launch-One-Acquisition-Corp-Completes-230-0-Million-Initial-Public-Offering.html
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 30 at 12:45 PM
$LPAA Minovia Therapeutics' MNV-201 Receives FDA Fast Track And Rare Pediatric Disease Designations For Pearson Syndrome Treatment
0 · Reply
DonCorleone77
DonCorleone77 Jun. 30 at 12:36 PM
$LPAA Minovia announces FDA Fast Track, RPD designations to MNV-201 Minovia Therapeutics announces that the U.S. Food and Drug Administration, FDA, has granted Fast Track Designation to the Company's lead investigational compound, MNV-201. The FDA has also granted Rare Pediatric Disease, RPD, Designation to MNV-201, which is in Phase 2 clinical trials for the treatment of Pearson Syndrome, an ultra-rare and life-threatening mitochondrial disorder affecting children.
0 · Reply
PenkeInvesting
PenkeInvesting Jun. 5 at 6:12 AM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Launch One Acquisition Corp. Class A Ordinary shares. Is that bullish or bearish? $LPAA #RsiOverbought #NASDAQ
0 · Reply
TerranceLyles191
TerranceLyles191 Jan. 1 at 4:49 PM
$LPAA The move to NVIDIA hardware has allowed AITX to accelerate production timelines, ensuring products reach customers faster and more efficiently.
0 · Reply
eewoodsjr
eewoodsjr Jan. 1 at 3:55 AM
$CERO https://app.quotemedia.com/data/downloadFiling?webmasterId=104887&ref=318818132&type=HTML This explains the drop on Dec 6th - 30th. Recovery starts next week? $LPAA and $CERO has the same CEO.
0 · Reply
eewoodsjr
eewoodsjr Dec. 28 at 6:22 AM
$CERO and $LPAA = same CEO. LPAA started trading Sept 3, 2024. 90 days later Ehrlich was named CEO of CERO Dec 6th. Not sure if this good or bad.. Any good DD is much appreciated. 👍🏾
1 · Reply
eewoodsjr
eewoodsjr Dec. 27 at 3:32 AM
$LPAA 1st!
0 · Reply